Rankings
Pricing
Log In
Free Trial
US-listed companies
PROKIDNEY CORP.
PROKIDNEY CORP.
PROK
Market cap
$562.69M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Net and comprehensive loss before noncontrolling interest
-
-148
Depreciation and amortization
-
3
Equity-based compensation
-
74
Prepaid and other assets
-
7
Accounts payable and accrued expenses
-
0
Income taxes payable
-
0
Net cash flows used in operating activities
-1,209,846
-77
Net cash from SCS
-
0
Purchase of equipment and facility expansion
-
2
Net cash flows used in investing activities
-250,000,000
-2
Payments on finance leases
-
0
Proceeds from Issuance of Common Stock
-
543
Proceeds from Related Party Debt
-
35
Repayment of related party notes payable
-
35
Net cash contribution
-
6
Net cash flows provided by financing activities
252
549
Net change in cash and cash equivalents
-
470
Income Taxes Paid, Net
-
2
Right of use assets obtained in exchange for lease obligations
-
1
Impact of equity transactions and compensation on redeemable noncontrolling interest
-
6
Equipment and facility expansion included in accounts payable and accrued expenses
-
0